LBO — SABINE MEDICAL CENTER
IRR: 20.3% | MOIC: 2.52x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
20.3%
IRR
2.52x
MOIC
$14.1M
Entry EV
$24.5M
Exit EV
$7.2M
Equity Invested
Sources & Uses
S&UTotal · $14.1M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $5.5M | 38.8% | |
| Sub Debt | $1.4M | 9.7% | |
| Equity | $7.2M | 51.5% | |
| Enterprise Value | $13.7M | 97.1% | |
| Transaction Fees | $0.4M | 2.9% | |
| Total Uses | $14.1M | 100.0% |
Interpretation
INTAt 2.52x MOIC and 20.3% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $2.3M |
| Exit Ev | $24.5M |
| Net Debt At Exit | $6.2M |
| Equity At Exit | $18.3M |
| Equity Invested | $7.2M |
| Total Value Created | $11.0M |
| Value From Growth | $10.1M |
| Value From Multiple | $0.7M |
| Value From Deleveraging | $0.6M |